R44GM148146
Project Grant
Overview
Grant Description
A conditional loss-of-function mutation collection in Drosophila.
Awardee
Funding Goals
THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (NIGMS) SUPPORTS BASIC RESEARCH THAT INCREASES OUR UNDERSTANDING OF BIOLOGICAL PROCESSES AND LAYS THE FOUNDATION FOR ADVANCES IN DISEASE DIAGNOSIS, TREATMENT, AND PREVENTION. NIGMS ALSO SUPPORTS RESEARCH IN SPECIFIC CLINICAL AREAS THAT AFFECT MULTIPLE ORGAN SYSTEMS: ANESTHESIOLOGY AND PERI-OPERATIVE PAIN; CLINICAL PHARMACOLOGY COMMON TO MULTIPLE DRUGS AND TREATMENTS; AND INJURY, CRITICAL ILLNESS, SEPSIS, AND WOUND HEALING. NIGMS-FUNDED SCIENTISTS INVESTIGATE HOW LIVING SYSTEMS WORK AT A RANGE OF LEVELSFROM MOLECULES AND CELLS TO TISSUES AND ORGANSIN RESEARCH ORGANISMS, HUMANS, AND POPULATIONS. ADDITIONALLY, TO ENSURE THE VITALITY AND CONTINUED PRODUCTIVITY OF THE RESEARCH ENTERPRISE, NIGMS PROVIDES LEADERSHIP IN SUPPORTING THE TRAINING OF FUTURE SCIENTISTS AND DEVELOPING RESEARCH CAPACITY THROUGHOUT THE COUNTRY.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Texas
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/24 to 08/31/25 and the total obligations have increased 104% from $893,628 to $1,824,506.
Genetivision Corporation was awarded
Project Grant R44GM148146
worth $1,824,506
from the National Institute of General Medical Sciences in September 2022 with work to be completed primarily in Texas United States.
The grant
has a duration of 3 years and
was awarded through assistance program 93.859 Biomedical Research and Research Training.
The Project Grant was awarded through grant opportunity PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed).
SBIR Details
Research Type
SBIR Phase II
Title
A Conditional Loss-of-Function Mutation Collection in Drosophila
Abstract
Project Summary/Abstract The overall goal of this proposal is to generate, maintain, and distribute a new collection of 2,800 conditional loss- and gain-of-function alleles for more than 1,400 Drosophila melanogaster genes that are highly conserved in humans. One key factor that sets Drosophila apart from other model systems is the huge wealth of genetic and molecular tools that have accumulated in the past 100 years of research. With a large, active Drosophila research community, additional technologies and tools that benefit the entire field can have a profound impact by accelerating the pace of research for many. Many of the most important advances in our understanding of human development have come from studies using the fruit fly as an animal model system. Since many parallels exist between Drosophila and mammals in terms of the underlying molecular mechanisms controlling biological processes, knowledge gained from research in Drosophila can be either directly applied or readily adapted to understanding human biology and disease. We propose to generate a collection of conditional flip-flop-loxP alleles that allow a specific gene to be turned off or on at any time in any cell type for a large fraction of the conserved genes in Drosophila. Therefore, the resulting collection is distinct from existing resources as it allows mitosis-independent modulation of gene activity, enabling mosaic analysis of gene function during different development stages and in adults. Moreover, this method allows restoration of gene function with full cell-type and temporal control. Therefore, this new collection will benefit virtually all Drosophila researchers; as such it is likely that there will be a high demand for this resource for many years to come. We propose to produce such alleles for 1,400 highly conserved genes. Our Specific Aims are to: Aim 1. Generate and validate 2,800 loss- and gain-of-function flip-flop-loxP alleles. Aim 2. Create and maintain an online searchable database for the flip-flop-loxP collection. This collection of conditional alleles will complement existing resources by adding significant capability to investigate gene function in any tissue/cell type in developing or adult flies by either knockout or restoration of function at any desired time. Once generated, this collection will offer great utility for the Drosophila research community. As clear evidence of the large size of the potential market, there are at least 2,000 Drosophila laboratories worldwide. Moreover, there are currently 2,567 projects funded by the NIH alone that have Drosophila in the title of the grant, comprising more than 1.1 billion USD in total costs per year. Since many grants that use Drosophila as a model system do not include the genus name in the title, these numbers are a clear underestimation of the potential market size. Thus, there is a large and actively funded research community that represents a substantial market for new reagents of broad utility.
Topic Code
400
Solicitation Number
PA21-259
Status
(Complete)
Last Modified 5/5/26
Period of Performance
9/1/22
Start Date
8/31/25
End Date
Funding Split
$1.8M
Federal Obligation
$0.0
Non-Federal Obligation
$1.8M
Total Obligated
Activity Timeline
Transaction History
Modifications to R44GM148146
Additional Detail
Award ID FAIN
R44GM148146
SAI Number
R44GM148146-4231122897
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Small Business
Awarding Office
75NS00 NIH National Institute of General Medical Sciences
Funding Office
75NS00 NIH National Institute of General Medical Sciences
Awardee UEI
DCR3JT98KGB7
Awardee CAGE
5HKB0
Performance District
TX-90
Senators
John Cornyn
Ted Cruz
Ted Cruz
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute of General Medical Sciences, National Institutes of Health, Health and Human Services (075-0851) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,824,506 | 100% |
Modified: 5/5/26